The more developed biomarkers become through research, the more clinicians will know about an individual injury — biomechanically in the brain — and then, the better they can develop and offer effective treatments.
See more videos with Dr. Ronald Hayes.
Posted on BrainLine April 2, 2013.
Produced by Brian King, Vicky Youcha, and Erica Queen, BrainLine.
About the author: Ronald Hayes, PhD
Ronald Hayes, PhD is a co-founder and president of Banyan Biomarkers, Inc. He is director of Banyan’s Clinical Programs and Banyan Laboratories.
